PE20050194A1 - Derivados de piridina-2-carboxamida como activadores de glucoquinasa - Google Patents

Derivados de piridina-2-carboxamida como activadores de glucoquinasa

Info

Publication number
PE20050194A1
PE20050194A1 PE2004000159A PE2004000159A PE20050194A1 PE 20050194 A1 PE20050194 A1 PE 20050194A1 PE 2004000159 A PE2004000159 A PE 2004000159A PE 2004000159 A PE2004000159 A PE 2004000159A PE 20050194 A1 PE20050194 A1 PE 20050194A1
Authority
PE
Peru
Prior art keywords
triazol
sulfanil
methyl
pyridine carboxamide
pyridine
Prior art date
Application number
PE2004000159A
Other languages
English (en)
Inventor
Morihiro Mitsuya
Makoto Bamba
Hitomi Watanabe
Teruyuki Nishimura
Jun-Ichi Eiki
Yasuhiro Sasaki
Fumiko Sakai
Original Assignee
Banyu Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Banyu Pharma Co Ltd filed Critical Banyu Pharma Co Ltd
Publication of PE20050194A1 publication Critical patent/PE20050194A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE REFIERE A COMPUESTOS DE FORMULA I, DONDE X1 ES N,S U O, O UN GRUPO DE HIDROCARBUROS(C1-C6) SATURADOS DIVALENTES QUE PUEDE PRESENTAR HETEROATOMOS DE N, O U S; R1 ES ARILO(C6-C10), HETEROALQUILO(C5-C10), CICLOALQUILO(C3-C7) O ALQUILO INFERIOR (DONDE R1 PUEDE ESTAR SUSTITUIDO POR AMINO, ALQUILO INFERIOR, ALCOXI INFERIOR, ENTRE OTROS; D ES O U S; R2 O R3 SON LOS MISMOS O DIFERENTES COMO H, ALQUILO, ALCOXI INFERIOR O HALOGENO. SON COMPUESTOS PREFERIDOS: 3-(4-FLUOR-FENILSULFANIL)-6-(4-METIL-4H-[1,2,4]TRIAZOL-3-IL-SULFANIL)-N-(4-METIL-TIAZOL-2-IL)-PIRIDINA CARBOXAMIDA, 3-(PIRIDIN-4-IL-SULFANIL)-6-(4H-[1,2,4]TRIAZOL-3-IL-SULFANIL-N-TRIAZOL-2-IL)-2-PIRIDINA CARBOXAMIDA, 3-(6-METOXI-PIRIDIN-3-ILSULFANIL)-6-(4H-[1,2,4]TRIAZOL-3-ILSULFANIL)-N-(1-METIL-1H-PIRAZOL-3-IL)-2-PIRIDINA CARBOXAMIDA, ENTRE OTROS. TAMBIEN SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE LO CONTIENE SOLO O ASOCIADO CON OTROS ACTIVADORES DE GLUCOQUINASA, BIS-GUANIDINA, UN AGONISTA DE PPAR, ENTRE OTROS. ESTOS COMPUESTOS SON ACTIVADORES DE LA ENZIMA GLUCOQUINASA Y SON UTILES PARA EL TRATAMIENTO Y/O PREVENCION DE DIABETES MELLITUS Y COMO UN AGENTE ANTIOBESIDAD
PE2004000159A 2003-02-13 2004-02-13 Derivados de piridina-2-carboxamida como activadores de glucoquinasa PE20050194A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2003034987 2003-02-13
JP2003342860 2003-10-01
JP2004014799 2004-01-22

Publications (1)

Publication Number Publication Date
PE20050194A1 true PE20050194A1 (es) 2005-04-23

Family

ID=32995582

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2004000159A PE20050194A1 (es) 2003-02-13 2004-02-13 Derivados de piridina-2-carboxamida como activadores de glucoquinasa

Country Status (21)

Country Link
US (3) US7629362B2 (es)
EP (1) EP1598349B1 (es)
JP (1) JP4400563B2 (es)
KR (1) KR20050101208A (es)
AR (1) AR045414A1 (es)
AT (1) ATE517887T1 (es)
AU (2) AU2004220234C1 (es)
BR (1) BRPI0407283A (es)
CA (1) CA2515841C (es)
EC (1) ECSP056016A (es)
HK (1) HK1088602A1 (es)
IL (1) IL169905A0 (es)
MA (1) MA27626A1 (es)
MX (1) MXPA05008619A (es)
NO (1) NO20054224L (es)
NZ (1) NZ540791A (es)
PE (1) PE20050194A1 (es)
TW (1) TWI336329B (es)
UA (1) UA82867C2 (es)
WO (1) WO2004081001A1 (es)
ZA (1) ZA200504852B (es)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7718644B2 (en) 2004-01-22 2010-05-18 The Trustees Of Columbia University In The City Of New York Anti-arrhythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2) and uses thereof
US7879840B2 (en) 2005-08-25 2011-02-01 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
US8022058B2 (en) 2000-05-10 2011-09-20 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
SE0102299D0 (sv) 2001-06-26 2001-06-26 Astrazeneca Ab Compounds
PL375021A1 (en) 2002-10-03 2005-11-14 Novartis Ag Substituted (thiazol-2-yl) -amide or sulfonamide as glycokinase activators useful in the treatment of type 2 diabetes
GB0226930D0 (en) 2002-11-19 2002-12-24 Astrazeneca Ab Chemical compounds
GB0226931D0 (en) 2002-11-19 2002-12-24 Astrazeneca Ab Chemical compounds
BRPI0407283A (pt) 2003-02-13 2006-01-31 Banyu Pharma Co Ltd Composto, composição farmacêutica, e, agente ativador de glucoquinase, agentes terapêuticos e/ou agentes preventivos para diabetes melito e obesidade
CA2553160C (en) * 2003-12-29 2010-09-28 Banyu Pharmaceutical Co., Ltd. 2-heteroaryl-substituted benzimidazole derivative
US8710045B2 (en) 2004-01-22 2014-04-29 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the ryanodine receptors
WO2005079802A1 (en) * 2004-02-12 2005-09-01 Merck & Co., Inc. Bipyridyl amides as modulators of metabotropic glutamate receptor-5
BRPI0509573A (pt) 2004-04-02 2007-09-25 Novartis Ag derivados de sulfonamida-tiazolpiridina como ativadores de glicocinase úteis para o tratamento de diabetes do tipo 2
JP2007530631A (ja) 2004-04-02 2007-11-01 ノバルティス アクチエンゲゼルシャフト チアゾロピリジン誘導体、それを含む医薬組成物およびグルコキナーゼ介在性状態の処置法
CN101068777A (zh) * 2004-10-08 2007-11-07 万有制药株式会社 硫醚化合物的制备方法
JP5036316B2 (ja) 2004-11-02 2012-09-26 Ｍｓｄ株式会社 アリールオキシ置換ベンズイミダゾール誘導体
WO2006090915A1 (en) * 2005-02-25 2006-08-31 Takeda Pharmaceutical Company Limited Pyridyl acetic acid compounds
KR100929942B1 (ko) 2005-03-04 2009-12-04 에프. 호프만-라 로슈 아게 Ｍｇｌｕｒ５ 길항제로서 피리딘-2-카복사미드 유도체
ATE466003T1 (de) 2005-08-05 2010-05-15 Bristol Myers Squibb Co Herstellung von 2-aminothiazol-5- carbonsäurederivaten
US7704990B2 (en) 2005-08-25 2010-04-27 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
JP2007063225A (ja) 2005-09-01 2007-03-15 Takeda Chem Ind Ltd イミダゾピリジン化合物
AU2006299091A1 (en) 2005-09-29 2007-04-12 Sanofi-Aventis Phenyl- and pyridinyl- 1, 2 , 4 - oxadiazolone derivatives, processes for their preparation and their use as pharmaceuticals
CA2623958C (en) * 2005-09-30 2013-05-28 Banyu Pharmaceutical Co., Ltd. 2-heteroaryl-substituted indole derivative
GT200600429A (es) 2005-09-30 2007-04-30 Compuestos organicos
GT200600428A (es) 2005-09-30 2007-05-21 Compuestos organicos
CA2624413A1 (en) 2005-10-05 2007-04-12 F. Hoffmann-La Roche Ag Naphthyridin derivatives
JP5137207B2 (ja) * 2005-11-01 2013-02-06 アレイ バイオファーマ、インコーポレイテッド グルコキナーゼ活性化因子
EP2001875A2 (en) 2006-03-08 2008-12-17 Takeda San Diego, Inc. Glucokinase activators
MY148985A (en) * 2006-03-24 2013-06-28 Array Biopharma Inc 2-aminopyridine analogs as glucokinase activators
PE20080251A1 (es) 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
ATE522518T1 (de) 2006-05-31 2011-09-15 Takeda San Diego Inc Indazol- und isoindolderivate als glucokinaseaktivierende stoffe
AU2007278261A1 (en) 2006-07-24 2008-01-31 F. Hoffmann-La Roche Ag Pyrazoles as glucokinase activators
AR063028A1 (es) 2006-10-06 2008-12-23 Banyu Pharma Co Ltd Derivados heterociclicos de piridin-2-carboxamida activadores de glucoquinasas, utiles para el tratamiento de diabetes y obesidad y composiciones farmaceuticas que los contienen.
EP2086973B1 (en) * 2006-10-11 2012-01-25 Amgen Inc., Imidazo- and triazolo-pyridine compounds and methods of use therof
WO2008079787A2 (en) 2006-12-20 2008-07-03 Takeda San Diego, Inc. Glucokinase activators
WO2008084872A1 (ja) 2007-01-10 2008-07-17 Mitsubishi Tanabe Pharma Corporation ヒドラゾン誘導体
US8431713B2 (en) 2007-01-24 2013-04-30 Array Biopharma, Inc. 2-aminopyridine derivatives as glucokinase activators
US8173645B2 (en) 2007-03-21 2012-05-08 Takeda San Diego, Inc. Glucokinase activators
JP5450108B2 (ja) * 2007-03-23 2014-03-26 アレイ バイオファーマ、インコーポレイテッド グルコキナーゼ活性化剤としての２−アミノピリジン類似体
JP2010138073A (ja) * 2007-03-30 2010-06-24 Taisho Pharmaceutical Co Ltd ピコリン酸アミド化合物
US20100190980A1 (en) * 2007-06-21 2010-07-29 Taisho Pharmaceutical Co., Ltd Pyrazinamide compound
EP2020232A1 (en) * 2007-08-03 2009-02-04 Zeltia, S.A. N-(1-thiazolyl)-amide derivatives for the treatment of obesity, diabetes and cardiovascular diseases
CA2699718C (en) 2007-09-21 2014-05-27 Array Biopharma Inc. Pyridin-2-yl-amino-1, 2, 4-thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitus
GB0719803D0 (en) 2007-10-10 2007-11-21 Cancer Rec Tech Ltd Therapeutic compounds and their use
PE20091565A1 (es) 2007-11-06 2009-11-06 Astrazeneca Ab Derivados de 2-pirazinona como inhibidores de la elastasa de los neutrofilos
JP5301456B2 (ja) 2007-11-12 2013-09-25 Ｍｓｄ株式会社 ヘテロアリールオキシキナゾリン誘導体
WO2009081782A1 (ja) 2007-12-25 2009-07-02 Banyu Pharmaceutical Co., Ltd. Ｎ－ピラゾール－２－ピリジンカルボキサミド誘導体
WO2009083553A1 (en) * 2007-12-31 2009-07-09 Rheoscience A/S Azine compounds as glucokinase activators
JP2011513253A (ja) * 2008-02-27 2011-04-28 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング 糖尿病を治療するためのカルボキサミド−ヘテロアリール誘導体
JP5498025B2 (ja) * 2008-03-13 2014-05-21 公益財団法人相模中央化学研究所 新規なチアゾール誘導体固定化マトリックス、及びその製造方法
WO2009113637A1 (ja) * 2008-03-12 2009-09-17 東ソー株式会社 新規なチアゾール誘導体、チアゾール誘導体固定化マトリックス、及びそれらの製造方法
JP5455380B2 (ja) * 2008-03-12 2014-03-26 公益財団法人相模中央化学研究所 新規なチアゾール誘導体、及びその製造方法
US8258134B2 (en) 2008-04-16 2012-09-04 Hoffmann-La Roche Inc. Pyridazinone glucokinase activators
US7741327B2 (en) * 2008-04-16 2010-06-22 Hoffmann-La Roche Inc. Pyrrolidinone glucokinase activators
EP2328889B1 (en) 2008-08-15 2016-01-06 Msd K.K. Acetyl pyrrolidinyl indole derivative
US8609699B2 (en) * 2008-08-29 2013-12-17 Msd K.K. Oxotetrahydrofuran-2-yl-benzimidazole derivative
NZ591366A (en) 2008-09-11 2012-05-25 Pfizer Heteroaryls amide derivatives and their use as glucokinase activators
WO2010056717A1 (en) 2008-11-17 2010-05-20 Merck Sharp & Dohme Corp. Substituted bicyclic amines for the treatment of diabetes
TW201036957A (en) * 2009-02-20 2010-10-16 Astrazeneca Ab Novel salt 628
KR101295937B1 (ko) * 2009-03-11 2013-08-14 화이자 인코포레이티드 글루코카이네이즈 억제제로서 사용되는 벤조푸라닐 유도체
US20110021570A1 (en) * 2009-07-23 2011-01-27 Nancy-Ellen Haynes Pyridone glucokinase activators
WO2011011506A1 (en) 2009-07-23 2011-01-27 Schering Corporation Spirocyclic oxazepine compounds as stearoyl-coenzyme a delta-9 desaturase inhibitors
WO2011011508A1 (en) 2009-07-23 2011-01-27 Schering Corporation Benzo-fused oxazepine compounds as stearoyl-coenzyme a delta-9 desaturase inhibitors
NZ713361A (en) 2009-08-17 2017-06-30 Memorial Sloan Kettering Cancer Center Heat shock protein binding compounds, compositions, and methods for making and using same
JP5750050B2 (ja) 2009-12-04 2015-07-15 大正製薬株式会社 ２−ピリドン化合物
US8222416B2 (en) 2009-12-14 2012-07-17 Hoffmann-La Roche Inc. Azaindole glucokinase activators
US8178689B2 (en) 2010-06-17 2012-05-15 Hoffman-La Roche Inc. Tricyclic compounds
KR20140145624A (ko) 2012-04-16 2014-12-23 카네크 파마 인코포레이티드 Ptp-1b 억제제에 대한 전구체로서의 융합된 방향족 포스포네이트 유도체
US9527838B2 (en) * 2012-12-17 2016-12-27 Merck Sharp & Dohme Corp. 2-pyridinecarboxamide derivatives, compositions containing such compounds, and methods of treatment
EP3143013B1 (en) 2014-05-13 2019-12-18 Memorial Sloan Kettering Cancer Center Hsp70 modulators and methods for making and using the same
US20240067657A1 (en) * 2020-12-29 2024-02-29 Merck Sharp & Dohme Llc Amido-substituted pyridyl compounds and methods of use thereof for the treatment of herpesviruses

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3536809A (en) 1969-02-17 1970-10-27 Alza Corp Medication method
US3598123A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3630200A (en) 1969-06-09 1971-12-28 Alza Corp Ocular insert
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4008719A (en) 1976-02-02 1977-02-22 Alza Corporation Osmotic system having laminar arrangement for programming delivery of active agent
JPS56115784A (en) * 1980-02-15 1981-09-11 Tanabe Seiyaku Co Ltd Novel pyridinecarboxamide derivative and its preparation
JPS5795984A (en) 1980-12-05 1982-06-15 Tanabe Seiyaku Co Ltd Pyridinecarboxamide derivative and its preparation
JPS58121215A (ja) 1982-01-14 1983-07-19 Tanabe Seiyaku Co Ltd 抗アレルギ−剤
CH680582A5 (es) 1991-04-23 1992-09-30 Supermatic Kunststoff Ag
GB2277930A (en) 1993-05-11 1994-11-16 Shell Int Research Herbicidal picolinamide derivatives
US6022884A (en) * 1997-11-07 2000-02-08 Amgen Inc. Substituted pyridine compounds and methods of use
GB9725298D0 (en) 1997-11-28 1998-01-28 Zeneca Ltd Insecticidal thiazole derivatives
JP2002047278A (ja) 2000-08-02 2002-02-12 Fuji Photo Film Co Ltd チオエーテル化合物の製造方法
JP4723059B2 (ja) 2000-08-03 2011-07-13 帝人化成株式会社 難燃性熱可塑性樹脂組成物
SE0102300D0 (sv) 2001-06-26 2001-06-26 Astrazeneca Ab Compounds
SE0102764D0 (sv) 2001-08-17 2001-08-17 Astrazeneca Ab Compounds
AU2002952839A0 (en) * 2002-11-21 2002-12-05 Fujisawa Pharmaceutical Co., Ltd. Aminoalcohol derivatives
BRPI0407283A (pt) 2003-02-13 2006-01-31 Banyu Pharma Co Ltd Composto, composição farmacêutica, e, agente ativador de glucoquinase, agentes terapêuticos e/ou agentes preventivos para diabetes melito e obesidade
RU2330030C2 (ru) 2003-02-26 2008-07-27 Баниу Фармасьютикал Ко., Лтд. Производные гетероарилкарбамоилбензола
GB0327761D0 (en) 2003-11-29 2003-12-31 Astrazeneca Ab Compounds
ES2322709T3 (es) 2004-02-18 2009-06-25 Astrazeneca Ab Derivados de benzamida y su uso como agentes activadores de la glucocinasa.
CA2554686A1 (en) 2004-02-18 2005-09-01 Astrazeneca Ab Compounds
CN101068777A (zh) * 2004-10-08 2007-11-07 万有制药株式会社 硫醚化合物的制备方法
AR063028A1 (es) * 2006-10-06 2008-12-23 Banyu Pharma Co Ltd Derivados heterociclicos de piridin-2-carboxamida activadores de glucoquinasas, utiles para el tratamiento de diabetes y obesidad y composiciones farmaceuticas que los contienen.
AR068540A1 (es) 2007-09-28 2009-11-18 Merck & Co Inc Metodos de produccion de un derivado de pirazol-3-il-benzamida.

Also Published As

Publication number Publication date
AR045414A1 (es) 2005-10-26
UA82867C2 (en) 2008-05-26
US20100041660A1 (en) 2010-02-18
AU2010200004A1 (en) 2010-01-28
ZA200504852B (en) 2006-05-31
NO20054224D0 (no) 2005-09-12
US20060258701A1 (en) 2006-11-16
TWI336329B (en) 2011-01-21
ECSP056016A (es) 2006-01-27
BRPI0407283A (pt) 2006-01-31
EP1598349B1 (en) 2011-07-27
WO2004081001A1 (ja) 2004-09-23
NZ540791A (en) 2009-09-25
CA2515841A1 (en) 2004-09-23
ATE517887T1 (de) 2011-08-15
AU2004220234C1 (en) 2013-01-17
US8765789B2 (en) 2014-07-01
US8344003B2 (en) 2013-01-01
EP1598349A1 (en) 2005-11-23
AU2004220234B2 (en) 2009-11-26
KR20050101208A (ko) 2005-10-20
EP1598349A4 (en) 2008-12-31
TW200510381A (en) 2005-03-16
MXPA05008619A (es) 2005-11-04
US20130085156A1 (en) 2013-04-04
JP4400563B2 (ja) 2010-01-20
AU2010200004B2 (en) 2012-07-19
CA2515841C (en) 2010-06-01
AU2004220234A1 (en) 2004-09-23
JPWO2004081001A1 (ja) 2006-06-08
NO20054224L (no) 2005-11-10
HK1088602A1 (en) 2006-11-10
US7629362B2 (en) 2009-12-08
MA27626A1 (fr) 2005-11-01
IL169905A0 (en) 2007-07-04

Similar Documents

Publication Publication Date Title
PE20050194A1 (es) Derivados de piridina-2-carboxamida como activadores de glucoquinasa
JP4583760B2 (ja) 疼痛の治療に有用な治療薬
NO20064929L (no) Sulfonamid-tiazolpyrldinderivater som glukokinaseaktivatorer anvendelige i behandlingen av type 2 diabetes
NO20056010L (no) Biaryloksymetylaren-karboksylsyrer
JP4663984B2 (ja) 疼痛の治療または防止に有用なチアジアゾリルピペラジン誘導体
PE20060316A1 (es) Derivados de prolina como inhibidores de dipeptidil peptidasa-iv
PE20030940A1 (es) Derivados de piridina y pirimidina
ATE487715T1 (de) Triazolderivate als modulatoren von dopamin-d3- rezeptoren
PE20070491A1 (es) Compuestos derivados de 9-azabiciclo[3.3.1]nonano como inhibidores de la recaptacion de neurotransmisores de monoamina
TNSN05320A1 (en) Pyrido` 2, 1-a - isoquinoline derivatives as dpp-iv inhibitors
TW200718424A (en) Novel compounds of amino sulfonyl derivatives
NO20051103L (no) Indol-3-karboksamider som Glukokinase-(GK)-Aktivatorer
NO20072608L (no) Biaryloksymetylarenkarboksylsyrer
MX2010002772A (es) Derivados de piridin-2-il-amino-1,2,4-tiadiazol como activadores de glucocinasa para el tratamiento de diabetes mellitus.
NO20075623L (no) Benzodioksan- og benzodioksolanderivater og deres anvendelse
PE20060873A1 (es) Compuestos de quinolina heteroaromaticos
TW200745037A (en) Organic compounds
PE20120620A1 (es) Dihidropirazolonas sustituidas como inhibidores de hif-propil-4-hidroxilasas
WO2007036532A3 (de) Ausgewählte cgrp-antagonisten, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
NO20055680L (no) Heksahydropyridoisokinoliner som DPP-IV-inhibitorer
DE602006019221D1 (de) Von dopamin-d3-rezeptoren
ATE464889T1 (de) Medizinische verwendung von hemmern von glutaminyl und glutamatcyclasen
NO20066055L (no) Pyridinderivater
PE20091724A1 (es) Derivados de indol como moduladores del receptor nicotinico de acetilcolina alfa 7
WO2008076243A3 (en) Acyl bipiperidinyl compounds, compositions containing such compounds and methods of treatment

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed